145 related articles for article (PubMed ID: 20224049)
1. Aneuploidy detection in mixed DNA samples by methylation-sensitive amplification and microarray analysis.
Brown L; Brown G; Vacek P; Brown S
Clin Chem; 2010 May; 56(5):805-13. PubMed ID: 20224049
[TBL] [Abstract][Full Text] [Related]
2. Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21.
Chim SS; Jin S; Lee TY; Lun FM; Lee WS; Chan LY; Jin Y; Yang N; Tong YK; Leung TY; Lau TK; Ding C; Chiu RW; Lo YM
Clin Chem; 2008 Mar; 54(3):500-11. PubMed ID: 18202156
[TBL] [Abstract][Full Text] [Related]
3. Quantification of fetal DNA by use of methylation-based DNA discrimination.
Nygren AO; Dean J; Jensen TJ; Kruse S; Kwong W; van den Boom D; Ehrich M
Clin Chem; 2010 Oct; 56(10):1627-35. PubMed ID: 20729299
[TBL] [Abstract][Full Text] [Related]
4. Microarray-Based Analysis of Methylation Status of CpGs in Placental DNA and Maternal Blood DNA--Potential New Epigenetic Biomarkers for Cell Free Fetal DNA-Based Diagnosis.
Hatt L; Aagaard MM; Graakjaer J; Bach C; Sommer S; Agerholm IE; Kølvraa S; Bojesen A
PLoS One; 2015; 10(7):e0128918. PubMed ID: 26230497
[TBL] [Abstract][Full Text] [Related]
5. Epigenome-wide DNA methylation assay reveals placental epigenetic markers for noninvasive fetal single-nucleotide polymorphism genotyping in maternal plasma.
Ou X; Wang H; Qu D; Chen Y; Gao J; Sun H
Transfusion; 2014 Oct; 54(10):2523-33. PubMed ID: 24749853
[TBL] [Abstract][Full Text] [Related]
6. Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies.
Papageorgiou EA; Fiegler H; Rakyan V; Beck S; Hulten M; Lamnissou K; Carter NP; Patsalis PC
Am J Pathol; 2009 May; 174(5):1609-18. PubMed ID: 19349366
[TBL] [Abstract][Full Text] [Related]
7. [Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].
Hou QF; Wu D; Chu Y; Kang B; Liao SX; Yang YL; Zhang CY; Zhang JX; Wu G
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):813-7. PubMed ID: 23302120
[TBL] [Abstract][Full Text] [Related]
8. Mrassf1a-pap, a novel methylation-based assay for the detection of cell-free fetal DNA in maternal plasma.
van den Oever JM; Balkassmi S; Segboer T; Verweij EJ; van der Velden PA; Oepkes D; Bakker E; Boon EM
PLoS One; 2013; 8(12):e84051. PubMed ID: 24391879
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis.
Chan KC; Ding C; Gerovassili A; Yeung SW; Chiu RW; Leung TN; Lau TK; Chim SS; Chung GT; Nicolaides KH; Lo YM
Clin Chem; 2006 Dec; 52(12):2211-8. PubMed ID: 17068167
[TBL] [Abstract][Full Text] [Related]
10. Detection of restriction enzyme-digested target DNA by PCR amplification using a stem-loop primer: application to the detection of hypomethylated fetal DNA in maternal plasma.
Tong YK; Chiu RW; Leung TY; Ding C; Lau TK; Leung TN; Lo YM
Clin Chem; 2007 Nov; 53(11):1906-14. PubMed ID: 17901110
[TBL] [Abstract][Full Text] [Related]
11. Screening significantly hypermethylated genes in fetal tissues compared with maternal blood using a methylated-CpG island recovery assay-based microarray.
Yin A; Zhang X; Wu J; Du L; He T; Zhang X
BMC Med Genomics; 2012 Jun; 5():26. PubMed ID: 22709530
[TBL] [Abstract][Full Text] [Related]
12. A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.
Bauer M; Hutterer G; Eder M; Majer S; Leshane E; Johnson KL; Peter I; Bianchi DW; Pertl B
Prenat Diagn; 2006 Sep; 26(9):831-6. PubMed ID: 16832830
[TBL] [Abstract][Full Text] [Related]
13. Whole genome bisulfite sequencing of cell-free DNA and its cellular contributors uncovers placenta hypomethylated domains.
Jensen TJ; Kim SK; Zhu Z; Chin C; Gebhard C; Lu T; Deciu C; van den Boom D; Ehrich M
Genome Biol; 2015 Apr; 16(1):78. PubMed ID: 25886572
[TBL] [Abstract][Full Text] [Related]
14. A microarray-based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease.
Chu T; Burke B; Bunce K; Surti U; Allen Hogge W; Peters DG
Prenat Diagn; 2009 Nov; 29(11):1020-30. PubMed ID: 19650061
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive prenatal methylomic analysis by genomewide bisulfite sequencing of maternal plasma DNA.
Lun FM; Chiu RW; Sun K; Leung TY; Jiang P; Chan KC; Sun H; Lo YM
Clin Chem; 2013 Nov; 59(11):1583-94. PubMed ID: 23857673
[TBL] [Abstract][Full Text] [Related]
16. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: Theoretical and empirical considerations.
Tong YK; Ding C; Chiu RW; Gerovassili A; Chim SS; Leung TY; Leung TN; Lau TK; Nicolaides KH; Lo YM
Clin Chem; 2006 Dec; 52(12):2194-202. PubMed ID: 17040955
[TBL] [Abstract][Full Text] [Related]
18. PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies.
Bianchi DW; Williams JM; Sullivan LM; Hanson FW; Klinger KW; Shuber AP
Am J Hum Genet; 1997 Oct; 61(4):822-9. PubMed ID: 9382092
[TBL] [Abstract][Full Text] [Related]
19. Differential DNA methylation as a tool for noninvasive prenatal diagnosis (NIPD) of X chromosome aneuploidies.
Della Ragione F; Mastrovito P; Campanile C; Conti A; Papageorgiou EA; Hultén MA; Patsalis PC; Carter NP; D'Esposito M
J Mol Diagn; 2010 Nov; 12(6):797-807. PubMed ID: 20847278
[TBL] [Abstract][Full Text] [Related]
20. Effects of Maternal and Fetal Characteristics on Cell-Free Fetal DNA Fraction in Maternal Plasma.
Zhou Y; Zhu Z; Gao Y; Yuan Y; Guo Y; Zhou L; Liao K; Wang J; Du B; Hou Y; Chen Z; Chen F; Zhang H; Yu C; Zhao L; Lau TK; Jiang F; Wang W
Reprod Sci; 2015 Nov; 22(11):1429-35. PubMed ID: 25963912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
